These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 23712541)

  • 1. Reducing the risk of obesity: defining the role of weight loss drugs.
    Ling H; Lenz TL; Burns TL; Hilleman DE
    Pharmacotherapy; 2013 Dec; 33(12):1308-21. PubMed ID: 23712541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight loss strategies for treatment of obesity.
    Kushner RF
    Prog Cardiovasc Dis; 2014; 56(4):465-72. PubMed ID: 24438739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent concepts of pharmacotherapy and bariatric surgery for childhood obesity: an overview.
    Gogakos A; Tzotzas TC; Krassas GE
    Pediatr Endocrinol Rev; 2009 Dec; 7(2):3-14. PubMed ID: 20118889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.
    Verpeut JL; Bello NT
    Expert Opin Drug Saf; 2014 Jun; 13(6):831-41. PubMed ID: 24766397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of obesity.
    Bray GA; Frühbeck G; Ryan DH; Wilding JP
    Lancet; 2016 May; 387(10031):1947-56. PubMed ID: 26868660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do we need anti-obesity drugs?
    Hainer V; Hainerová IA
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():8-20. PubMed ID: 23280861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-obesity drugs: a review about their effects and their safety.
    Derosa G; Maffioli P
    Expert Opin Drug Saf; 2012 May; 11(3):459-71. PubMed ID: 22439841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?
    Woloshin S; Schwartz LM
    JAMA Intern Med; 2014 Apr; 174(4):615-9. PubMed ID: 24515599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity - an epidemic of the twenty-first century: an update for psychiatrists.
    Holt RI
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):6-15. PubMed ID: 16280333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for the management of obesity.
    Patel D
    Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of obesity in 2015.
    Shukla AP; Buniak WI; Aronne LJ
    J Cardiopulm Rehabil Prev; 2015; 35(2):81-92. PubMed ID: 25714749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medications for weight loss.
    Mordes JP; Liu C; Xu S
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):91-7. PubMed ID: 25692921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New medications for treatment of obesity: metabolic and cardiovascular effects.
    Pucci A; Finer N
    Can J Cardiol; 2015 Feb; 31(2):142-52. PubMed ID: 25661549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.
    Walter CP; Bleske BE; Dorsch MP
    J Clin Pharm Ther; 2014 Oct; 39(5):475-84. PubMed ID: 24924286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological approaches to intervention.
    Guy-Grand B
    Int J Obes Relat Metab Disord; 1997 Mar; 21 Suppl 1():S22-4. PubMed ID: 9130037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy.
    Kushner RF
    Prog Cardiovasc Dis; 2018; 61(2):246-252. PubMed ID: 29890171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on obesity pharmacotherapy.
    Bray GA; Ryan DH
    Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Past, present and future of pharmacotherapy for obesity.
    Benaiges D; Pedro-Botet J; Flores-Le Roux JA; Climent E; Goday A
    Clin Investig Arterioscler; 2017; 29(6):256-264. PubMed ID: 28935287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New obesity agents: lorcaserin and phentermine/topiramate.
    Fleming JW; McClendon KS; Riche DM
    Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.